You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Case report
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy

 

Online download statistics by month:

Online download statistics by month: August 2020 to February 2026

AbstractFullPdf
Aug 202010461047209
Sep 2020343343116
Oct 202025525769
Nov 202024224174
Dec 202025125168
Jan 202122422458
Feb 202126826873
Mar 202128128162
Apr 202132932937
May 202119919950
Jun 2021686825
Jul 2021909142
Aug 2021858545
Sep 2021949457
Oct 202111011052
Nov 2021747442
Dec 2021666621
Jan 2022747625
Feb 2022778018
Mar 2022859220
Apr 2022717322
May 2022596022
Jun 2022636717
Jul 202222222620
Aug 2022707217
Sep 2022383917
Oct 2022384119
Nov 2022414314
Dec 202232328
Jan 2023454516
Feb 2023626315
Mar 202372729
Apr 2023293016
May 2023525514
Jun 202319198
Jul 202332328
Aug 2023313218
Sep 202326269
Oct 202319197
Nov 2023191917
Dec 202358599
Jan 20241011039
Feb 2024606112
Mar 2024343470
Apr 2024272823
May 2024222313
Jun 2024454420
Jul 202444459
Aug 2024393812
Sep 202425349
Oct 2024282813
Nov 2024424311
Dec 2024767619
Jan 2025313215
Feb 202513213213
Mar 202542427
Apr 2025535317
May 2025283010
Jun 202510010019
Jul 2025110
Aug 2025100
Sep 2025110
Dec 2025200
Feb 2026310
Total629663491766